Pharmacopeia
Officials at Pharmacopeia announce latest news and research developments
Published in Lab Business Week, March 25th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Pharmacopeia.
Report 1: Pharmacopeia (PCOP) announced the signing of an exclusive research and license agreement with Wyeth Pharmaceuticals, a division of Wyeth (WYE). The alliance is based on Pharmacopeia's JAK3 inhibitor program and it will be focused on the research, development and commercialization of JAK3 inhibitor-based therapeutic products.
Inhibition of JAK3 has been shown in both preclinical and clinical studies to modulate disease outcomes, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-03-25)
More Articles from Lab Business Week
- Auriga Laboratories, Inc.
Auriga Laboratories Promotes Alan Roberts to Chief Scientific Officer - Bio-Rad Laboratories
BIO-RAD'S RECENT APPOINTMENT OF NEW BOARD MEMBER BRINGS THE COMPANY INTO COMPLIANCE WITH THE AMERICAN STOCK EXCHANGE - Brain Research
Scientists at Gorlaeus Laboratories discuss research in brain research - Breast Cancer
US LABS Meets the ASCO/CAP Her-2 Guidelines - Cancer
Research on cancer described by scientists at Cold Spring Harbor Laboratory - Cancer Therapy
New cancer therapy findings from Abbott Laboratories described - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
